Emily Kai Yee Lam

Emily Kai Yee Lam

Auto-generated profile, based on publicly available information

Emily Kai Yee Lam

Department of Integrative Biology, University of California, Berkeley, Berkeley, California 94720, United States

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2005 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
WWWilliam Wu
William Wu
GLGui Rong Li
Gui Rong Li
HWHelen Pui Shan Wong
Helen Pui Shan Wong
MHMarco King Cheung Hui
Marco King Cheung Hui
ETEmily Kin Ki Tai
Emily Kin Ki Tai
CCChi Hin Cho
Chi Hin Cho

26 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AEAlexander J. Ehrenberg
Alexander J. Ehrenberg
EMErica A. Moehle
Erica A. Moehle
CBCara E. Brook
Cara E. Brook
ACAndrew H. Doudna Cate
Andrew H. Doudna Cate
LWLea B. Witkowsky
Lea B. Witkowsky
OCon behalf of the IGI SARS-CoV-2 Testing Consortium
on behalf of the IGI SARS-CoV-2 Testing Consortium
Regular surveillance testing of asymptomatic individuals for SARS-CoV-2 has been center to SARS-CoV-2 outbreak prevention on college and university campuses. Here we describe the voluntary saliva testing program instituted at the University of California, Berkeley during an early period of the SARS-CoV-2 pandemic in 2020. The program was administered as a research study ahead of clinical implementation, enabling us to launch surveillance testing while continuing to optimize the assay. Results of both the testing protocol itself and the study participants’ experience show how the program succeeded in providing routine, robust testing capable of contributing to outbreak prevention within a campus community and offer strategies for encouraging participation and a sense of civic responsibility.

15 September 2021 in Journal of Experimental Biology
Verified
Journal Article
Open access
PDF file
DEDavid C. Ensminger
David C. Ensminger
DCDaniel E. Crocker
Daniel E. Crocker
ELEmily K. Lam
Emily K. Lam
KAKaitlin N. Allen
Kaitlin N. Allen
Jose Pablo Vazquez-MedinaJose Pablo Vazquez-Medina
Jose Pablo Vazquez-Medina
The hypothalamic–pituitary–adrenal (HPA) axis controls the release of glucocorticoids, which regulate immune and inflammatory function by modulating cytokines, white blood cells and oxidative stress via glucocorticoid receptor (GR) signaling. Although the response to HPA activation is well characterized in many species, little is known about the impacts of HPA activation during extreme physiological conditions. Hence, we challenged 18 simultaneously fasting and developing elephant seal pups with daily intramuscular injections of adrenocorticotropin (ACTH), a GR antagonist (RU486), or a combination of the two (ACTH+RU486) for 4 days. We collected blood at baseline, 2 h and 4 days after the beginning of treatment. ACTH and ACTH+RU486 elevated serum aldosterone and cortisol at 2 h, with effects diminishing at 4 days. RU486 alone induced a compensatory increase in aldosterone, but not cortisol, at 4 days. ACTH decreased neutrophils at 2 h, while decreasing lymphocytes and increasing the neutrophil:lymphocyte ratio at 4 days. These effects were abolished by RU486. Despite alterations in white blood cells, there was no effect of ACTH or RU486 on transforming growth factor-β or interleukin-6 levels; however, both cytokines decreased with the 4 day fasting progression. Similarly, ACTH did not impact protein oxidation, lipid peroxidation or antioxidant enzymes, but plasma isoprostanes and catalase activity decreased while glutathione peroxidase increased with fasting progression. These data demonstrate differential acute (2 h) and chronic (4 days) modulatory effects of HPA activation on white blood cells and that the chronic effect is mediated, at least in part, by GR. These results also underscore elephant seals' extraordinary resistance to oxidative stress derived from repeated HPA activation.

1 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DEDavid C. Ensminger
David C. Ensminger
DCDaniel E. Crocker
Daniel E. Crocker
ELEmily K. Lam
Emily K. Lam
NKN. Allen Kaitlin
N. Allen Kaitlin
Jose Pablo Vazquez-MedinaJose Pablo Vazquez-Medina
Jose Pablo Vazquez-Medina
The hypothalamic-pituitary-adrenal (HPA) axis controls the release of glucocorticoids, which regulate immune and inflammatory function by modulating cytokines, white blood cells (WBCs), and oxidative stress via glucocorticoid receptor (GR) signaling. Although the response to HPA activation is well characterized in many species, little is known about the impacts of HPA activation during extreme physiological conditions in marine mammals. Hence, we challenged 18 simultaneously fasting and developing elephant seal pups with daily intramuscular injections of adrenocorticotropin (ACTH), a GR antagonist (RU486), or a combination (ACTH+RU486) for four days (4d). We collected blood at baseline, two hours (2h), and 4d after the beginning of treatment. ACTH and ACTH+RU486 elevated serum aldosterone and cortisol at 2h, with effects diminishing at 4d. RU486 alone induced a compensatory increase in aldosterone, but not cortisol, at 4d. ACTH decreased neutrophils at 2h while decreasing lymphocytes and increasing neutrophil:lymphocyte ratio at 4d. These effects were abolished by RU486. Despite alterations in WBCs, there was no effect of ACTH or RU486 on transforming growth factor-β or interleukin-6 levels; however, both cytokines decreased with the 4-d fasting progression. Similarly, ACTH did not impact protein oxidation, lipid peroxidation, or antioxidant enzymes, but plasma isoprostanes and catalase activity decreased while glutathione peroxidase increased with fasting progression. These data demonstrate differential acute (2h) and chronic (4d) modulatory effects of HPA activation on WBCs and that the chronic effect is mediated, at least in part, by GR. These results also underscore elephant seals’ resistance to potential oxidative stress derived from repeated HPA activation. Summary statement Many species experience oxidative stress and inflammation after repeated activation of the hypothalamic-pituitary-adrenal axis. We show that simultaneously fasting and developing elephant seals are resistant to repeated hypothalamic-pituitary-adrenal axis activation.

11 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EPElizabeth R. Piotrowski
Elizabeth R. Piotrowski
ELEmily K. Lam
Emily K. Lam
DMDiana D. Moreno-Santillán
Diana D. Moreno-Santillán
KAKaitlin N. Allen
Kaitlin N. Allen
DCDaniel E. Crocker
Daniel E. Crocker
Jose Pablo Vazquez-MedinaJose Pablo Vazquez-Medina
Jose Pablo Vazquez-Medina
This study investigated the transcriptional and bioenergetic responses to monoethylhexyl phthalate (MEHP) in primary fibroblasts derived from northern elephant seals ( Mirounga angustirostris ), common dolphins ( Delphinus delphis ), and humans, using RNA-seq, extracellular flux assays, and high-resolution microscopy of the mitochondrial reticulum. MEHP exposure did not induce cytotoxicity but triggered species-specific changes in gene expression and mitochondrial metabolism and morphology. Human cells showed the greatest transcriptional response, upregulating genes involved in detoxification, antioxidant, and inflammation while downregulating lipid metabolism pathways. The highest dose also decreased mitochondrial respiration and increased mitochondrial fragmentation, triggering a metabolic shift toward glycolysis. Elephant seal cells showed delayed glycolytic shifts, maintaining mitochondrial respiration and upregulating antioxidant, immune, and metabolic pathway genes through the highest dose. Despite mitochondrial fragmentation, they upregulated mitochondrial fusion/fission and trafficking genes. Dolphin cells exhibited the fewest changes in gene expression, mostly in hormone signaling and mitotic pathways. They showed dose-dependent declines in both respiration and glycolytic rates, even at the lowest concentration, yet maintained mitochondrial structural integrity while upregulating stress- and hypoxia-induced genes. These distinct strategies highlight species-specific susceptibility to toxicant-induced stress, offering new insights into how marine mammals respond to plastic-derived contaminants and reinforcing the need for species-specific ecotoxicological risk assessments.